All lobbying filings

MARSHALL & POPP, LLC

Lobbying for ELI LILLY AND COMPANY · Biopharmaceutical manufacturer.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Indiana · House · Senate · $60,000.00 income · posted Oct 20, 2025

Official filing document

Lobbying activity 2

Medicare/Medicaid

Issues related to treatments for Alzheimers therapeutics.

Pharmacy

Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals. Issues related to the 340B program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.